Bharat Parenterals Ltd — Updates, 12-05-2025: Company Update

Bharat Parenterals Limited has announced no deviation in the use of funds raised through its preferential equity issue of Rs. 95.60 Cr. The company has utilized Rs. 64.80 Cr towards investment in its subsidiary and Rs. 11.95 Cr for general corporate purposes. However, Rs. 7.17 Cr allocated for capital adequacy and business expansion remains unutilized as of the quarter-end. This disciplined fund utilization aligns with the company’s strategic objectives, maintaining transparency for shareholders.